Milestone Scientific to Present at the Aegis Capital Healthcare & Technology Conference in Las Vegas
Marketwire - Mon Sep 08, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Thursday, September 11th at 3:00 p.m. Pacific Time at the 2014 Aegis Capital Healthcare & Technology Conference at The Encore at Wynn in Las Vegas.
Milestone Scientific Announces Financial Results for the Second Quarter of 2014
Marketwire - Thu Aug 14, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results and provided a business update for the three and six months ended June 30, 2014.
Milestone Scientific Schedules Second Quarter 2014 Earnings Conference Call
Marketwire - Mon Aug 11, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 a.m. Eastern Time on Thursday, August 14, 2014 to discuss the Company's financial results for the second quarter ended June 30, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
Marketwire - Thu Jul 31, 11:18AM CDT
Milestone Scientific Inc. (OTCQB: MLLS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it has retained Maxim Group LLC, a leading premier investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting Milestone in its strategies for maximizing shareholder value through its full scope of investment banking services.
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant
Marketwire - Wed Jul 30, 6:32AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins to the position of Marketing Consultant.
Merriman Capital Initiates on Milestone Scientific, Inc. with a Buy Rating
Thomson Reuters ONE - Thu Jul 17, 8:45AM CDT
SAN FRANCISCO - July 17, 2014 - Merriman Capital, Inc. ("Merriman"
International Sales Continue to Boost Becton, Dickinson - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 5:15PM CDT
Becton, Dickinson (BDX) maintains its focus on geographical expansion into overseas markets, in particular, emerging markets
Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:39AM CDT
Antares Pharma has seen flat earnings estimate revisions for the current quarter along with a significant decline in its share price for the last day
First Taker for Becton, Dickinson's Cato Workflow Solution - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 12:10PM CDT
Becton, Dickinson and Company's (BDX) BD Cato Workflow Solution is an integrated software system that draws on barcode technology and gravimetric verification to enhance patient safety and optimize workflow efficiency in medication preparation.
CR Bard Expands Share Repurchase Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 12:40PM CDT
In addition, CR Bard (BCR) raised the quarterly dividend on its stock by 5% to 22 cents per share.
CR Bard's Lutonix DCB Moves Closer to FDA Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 2:40PM CDT
If sanctioned, CR Bard Inc.'s (BCR) Lutonix DCB is expected to be the first and only FDA-approved DCB in the U.S.
Becton, Dickinson Unveils Blood Culture Instrument Connectivity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 12:15PM CDT
Becton, Dickinson and Company (BDX) will now provide connectivity of the fully automated microbiology growth and detection technology BD BACTEC Blood Culture System with BD EpiCenter Microbiology Data Management System
Milestone Scientific Reports Fourth Quarter and 2013 Financial Results
Marketwire - Wed Mar 12, 6:08PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the fourth quarter and year ended December 31, 2013.
Milestone Scientific Anticipates Significant Increase in Wand(R) Handpiece Sales in Second Half of 2014
Marketwire - Mon Mar 10, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Aseptico, its exclusive dental distributor, will now only sell Milestone's STA Wand® handpieces directly to dentists and will no longer sell through third-party distributors. As a result, the Company announced that it anticipates increased Wand® handpiece sales in the second half of 2014 due to the greater transparency and direct contact it will have with dentists through Aseptico.
Milestone Scientific Schedules 2013 Year-End Earnings Conference Call
Marketwire - Fri Mar 07, 10:10AM CST
Milestone Scientific, Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Daylight Time on Thursday, March 13, 2014 to discuss the company's financial results for the fourth quarter and full year ending December 31, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific Announces Distribution Agreement With Henry Schein
Marketwire - Thu Aug 29, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced a distribution agreement with Henry Schein, Inc., the world's largest provider of health care products and services to medical, dental, and veterinary office-based practitioners. Under the agreement, Henry Schein will become the exclusive U.S. and Canadian distributor of Milestone's The Wand® handpiece associated with its CompuDent® instrument. The agreement does not apply to Milestone's existing distribution agreements relating to its STA Single Tooth Anesthesia System®.
Milestone Scientific to Present at 1st Global Life Sciences Conference in Warsaw
Marketwire - Wed Jul 17, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Leonard Osser, Chief Executive Officer, Joseph D'Agostino, Chief Financial Officer & Chief Operating Officer, and Mark Hochman, D.D.S., Director of Clinical Affairs, will present at the upcoming 1st Global Life Sciences Conference in Warsaw on September 16-17, 2013 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland. A recording of the presentation will be posted on Milestone's website following the conference.
Milestone Scientific and Tri-anim Health Services Form Strategic Partnership to Introduce Precision Injection Technology
Marketwire - Tue Jul 09, 8:40AM CDT
Milestone Scientific Inc. (OTCQB: MLSS) ("Milestone"